Breaking News Instant updates and real-time market news.

PGNX

Progenics

$5.74

0.02 (0.35%)

09:15
07/12/19
07/12
09:15
07/12/19
09:15

Progenics begins search process to identify new board candidates

Progenics Pharmaceuticals announced that, based on the preliminary voting results of its 2019 Annual Meeting of Shareholders, Progenics directors Mark Baker, Bradley Campbell, Karen Ferrante, David Scheinberg and Nicole Williams received a majority of the votes cast at the Annual Meeting, and Peter Crowley and Michael Kishbauch did not. In accordance with Progenics' bylaws, Crowley and Kishbauch have each submitted a contingent resignation which will become effective only if the certification of the votes of the Annual Meeting confirms that they did not receive a majority of the votes cast and the Board of Directors accepts the resignation. As required under the Company's bylaws, the Nominating and Corporate Governance Committee is considering these matters and will recommend to the Board the action to be taken with respect to the tendered contingent resignations. The Board will determine whether to accept such resignations, or what other action should be taken, in accordance with Progenics' bylaws.The Company also announced that the Board has retained Korn Ferry to help identify new Board candidates with relevant business, commercial and development experience.

PGNX Progenics
$5.74

0.02 (0.35%)

07/31/18
NEED
07/31/18
NO CHANGE
Target $16
NEED
Strong Buy
Progenics price target raised to $16 from $14 at Needham
Needham analyst Chad Messer raised his price target on Progenics to $16 after the FDA approved Azedra for intravenous use for certain types of locally advanced or metastatic pheochromocytoma or paraganglioma who require systemic anticancer therapy. Messer keeps a Strong Buy rating on Progenics shares.
09/13/18
NEED
09/13/18
DOWNGRADE
NEED
Buy
Progenics downgraded to Buy from Strong Buy at Needham
09/13/18
09/13/18
DOWNGRADE
Target $12

Buy
Progenics downgraded to Buy on Phase III trial disappointment at Needham
As previously reported, Needham analyst Chad Messer downgraded Progenics to Buy from Strong Buy after its Phase III study of PSMA imaging agent 1404 in prostate cancer missed its co-primary sensitivity endpoint. Although the study did meet the specificity endpoint, the analyst believes these results fall short of expectations set based on strong Phase II results. Additionally, Messer notes that the limitations of 1404 are likely due to the SPECT/CT platform and sees no read through to PyL, Progenic's other PSMA based imaging agent that works on the more sensitive PET imaging platform. The analyst also lowered his price target on the shares to $12 from $16.
12/07/18
FBCO
12/07/18
INITIATION
Target $6.5
FBCO
Outperform
Progenics initiated with an Outperform at Credit Suisse
Credit Suisse analyst Martin Auster initiated Progenics with an Outperform rating and $6.50 price target. In a research note to investors, Auster says he believes Progenics' royalties and future milestones from Relistor and revenue from Azedra support a core business with an NPV of about $5 per share, and says that as the commercial uptake of Azedra begins to unfold, investor focus is expected to turn to upside opportunities in prostate cancer PSMA-targeting diagnostic and therapeutic approaches. He adds that Novartis' (NVS) recent $2.1B acquisition of Endocyte (ECYT) supports pharma interest and attractive valuations in the space.

TODAY'S FREE FLY STORIES

WABC

Westamerica

$60.52

0.09 (0.15%)

11:00
07/18/19
07/18
11:00
07/18/19
11:00
Earnings
Westamerica reports Q2 EPS 73c, consensus 73c »

The company recognized no…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EVR

Evercore Partners

$88.51

0.725 (0.83%)

10:59
07/18/19
07/18
10:59
07/18/19
10:59
Periodicals
Evercore to lose out as Aramco reshuffles IPO roles, Reuters reports »

Evercore Partners has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 06

    Aug

MAS

Masco

$37.91

-0.71 (-1.84%)

10:55
07/18/19
07/18
10:55
07/18/19
10:55
Options
Masco put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

ADTN

Adtran

$15.25

-0.59 (-3.72%)

10:54
07/18/19
07/18
10:54
07/18/19
10:54
Earnings
Adtran sees Q3 revenue $130M-$150M, consensus $160.11M »

Sees Q3 gross margins…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

PHR

Phreesia

$0.00

(0.00%)

10:52
07/18/19
07/18
10:52
07/18/19
10:52
Syndicate
Breaking Syndicate news story on Phreesia »

Phreesia opens at $26.75,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TEVA

Teva

$7.90

-0.21 (-2.59%)

10:50
07/18/19
07/18
10:50
07/18/19
10:50
Periodicals
Teva's sinking bond price posing insolvency threat, Haaretz says »

The decline of Teva share…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

PHR

Phreesia

$0.00

(0.00%)

10:48
07/18/19
07/18
10:48
07/18/19
10:48
Syndicate
Breaking Syndicate news story on Phreesia »

Phreesia indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GMAB

Genmab

$0.00

(0.00%)

10:47
07/18/19
07/18
10:47
07/18/19
10:47
Syndicate
Breaking Syndicate news story on Genmab »

Genmab opens at $18.25,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

10:45
07/18/19
07/18
10:45
07/18/19
10:45
General news
Oil Action: WTI crude »

Oil Action: WTI crude is…

10:45
07/18/19
07/18
10:45
07/18/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
07/18/19
07/18
10:45
07/18/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

ZBRA

Zebra Technologies

$184.79

-12.87 (-6.51%)

10:44
07/18/19
07/18
10:44
07/18/19
10:44
Downgrade
Zebra Technologies rating change at Wellington Shields »

Zebra Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

ADTN

Adtran

$15.52

-0.32 (-2.02%)

10:43
07/18/19
07/18
10:43
07/18/19
10:43
Earnings
Adtran reports preliminary Q2 adjusted EPS 14c, consensus 8c »

Reports preliminary Q2…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

NFLX

Netflix

$324.70

-37.8 (-10.43%)

10:40
07/18/19
07/18
10:40
07/18/19
10:40
Options
Netflix selloff exceeds implied move level following earnings »

Netflix selloff exceeds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WORK

Slack Technologies

$33.01

-0.45 (-1.34%)

10:39
07/18/19
07/18
10:39
07/18/19
10:39
Hot Stocks
Slack resets passwords for 1% of its users because of 2015 hack »

Slack published details…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PHR

Phreesia

$0.00

(0.00%)

10:38
07/18/19
07/18
10:38
07/18/19
10:38
Syndicate
Breaking Syndicate news story on Phreesia »

Phreesia indicated to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

SONM

Sonim

$13.62

-0.18 (-1.30%)

10:38
07/18/19
07/18
10:38
07/18/19
10:38
Initiation
Sonim initiated at B. Riley FBR »

B. Riley FBR starts Sonim…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

  • 25

    Jul

  • 26

    Jul

  • 12

    Sep

NFLX

Netflix

$324.58

-37.92 (-10.46%)

, AMZN

Amazon.com

$1,983.50

-8.91 (-0.45%)

10:37
07/18/19
07/18
10:37
07/18/19
10:37
On The Fly
Analysts still see growth as Netflix slides following quarterly subscriber miss »

Shares of Netflix (NFLX)…

NFLX

Netflix

$324.58

-37.92 (-10.46%)

AMZN

Amazon.com

$1,983.50

-8.91 (-0.45%)

DIS

Disney

$141.18

-1.41 (-0.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 06

    Aug

NTAP

NetApp

$59.32

-0.03 (-0.05%)

10:35
07/18/19
07/18
10:35
07/18/19
10:35
Options
NetApp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FULC

Fulcrum Therapeutics

$0.00

(0.00%)

10:31
07/18/19
07/18
10:31
07/18/19
10:31
Syndicate
Fulcrum Therapeutics indicated to open at $15.00, IPO priced at $16.00 »

Fulcrum Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

10:30
07/18/19
07/18
10:30
07/18/19
10:30
General news
EIA natural gas storage change for week ending July 12 »

Gas inventories 62 Bcf…

AMK

AssetMark Financial

$0.00

(0.00%)

10:28
07/18/19
07/18
10:28
07/18/19
10:28
Syndicate
Breaking Syndicate news story on AssetMark Financial »

AssetMark Financial opens…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GMAB

Genmab

$0.00

(0.00%)

10:25
07/18/19
07/18
10:25
07/18/19
10:25
Syndicate
Breaking Syndicate news story on Genmab »

Genmab indicated to open…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

DISH

Dish

$40.74

-0.12 (-0.29%)

10:25
07/18/19
07/18
10:25
07/18/19
10:25
Options
Dish call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:25
07/18/19
07/18
10:25
07/18/19
10:25
Conference/Events
SunTrust technology analysts to hold an analyst/industry conference call »

Technology Analysts…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.